May 23, 2023
Preparation of Polymeric Implants for the Sustained Release of Polychlorinated Biphenyls (PCBs) and Their Derivatives
- Amanda J. Bullert1,
- Hui Wang1,
- Hansjoachim Lehmler1
- 1Department of Occupational and Environmental Health, University of Iowa, Iowa City, Iowa, USA, 52241
Protocol Citation: Amanda J. Bullert, Hui Wang, Hansjoachim Lehmler 2023. Preparation of Polymeric Implants for the Sustained Release of Polychlorinated Biphenyls (PCBs) and Their Derivatives. protocols.io https://dx.doi.org/10.17504/protocols.io.n2bvj667plk5/v1
License: This is an open access protocol distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited
Protocol status: Working
We use this protocol and it's working
Created: February 12, 2022
Last Modified: May 23, 2023
Protocol Integer ID: 58115
Keywords: implant, polymeric, polycaprolactone, subcutaneous, polychlorinated biphenyl, PCB, metabolite, preparation of polymeric polycaprolactone implant, polymeric polycaprolactone implant, preparation of polymeric implant, derivatives polymeric implant, polymeric implant, sustained release of polychlorinated biphenyl, hydroxylated polychlorinated biphenyl, polychlorinated biphenyl, such as polychlorinated biphenyl, implant, drug delivery system, sustained release
Funders Acknowledgements:
National Institute of Environmental Health Sciences
Grant ID: P42 ES013661
National Institute of Environmental Health Sciences
Grant ID: P30 ES005605
Abstract
Polymeric implants are a drug delivery system that can be grafted under the skin to allow for the continuous release of a particular substance or compound, such as polychlorinated biphenyls (PCBs) or their derivatives. In this protocol, we describe the preparation of polymeric polycaprolactone implants loaded with a hydroxylated polychlorinated biphenyl (PCB) metabolite or a related compound (i.e., biphenyl-4-ol). These implants can be grafted subcutaneously in rats to release the test compound continuously.
Materials
Chemicals list
- Polycaprolactone (P-80, Average Mn 80000, Sigma 440744-250G, Lot# MKCL0177)
- Pluronic (F-127, Sigma P2443-250G, Lot# BCCC2327)
- Dichloromethane, Pesticide grade (Fisher, D142-4)
Accessories
- Silastic (silicone) tubing (I.D. 0.104 inch x O.D. 0.192 inch, VWR International, 62999-868 )
- Disposable plastic syringe (5 mL)
- Oil bath
- Hot plate, with thermometer (IKA RCT basic hotplate with IKA ETS-D5 thermometer)
- 1 125 mL Beaker
- Glass rod
- Vacuum oven (Napco, model 5831)
Troubleshooting
Safety warnings
Dichloromethane (DCM) : Advice on safe handling Work under hood. Do not inhale substance/mixture. Avoid generation of vapours/aerosols. Hygiene measures Immediately change contaminated clothing. Apply preventive skin protection. Wash hands and face after working with substance. Do not breathe vapors, aerosols. Avoid substance contact. Ensure adequate ventilation.
Polychlorinated biphenyl (PCB): May cause damage to organs through prolonged or repeated exposure.Very toxic to aquatic life with long lasting effects. Do not breathe dust/fume/gas/mist/vapours/spray. Avoid release to the environment. This statement does not apply where this is the intended use. Get medical advice/attention if you feel unwell. Collect spillage. Dispose of contents/container in accordance with relevant regulations.
Before start
Always wear proper Personal Protective Equipment and work in a fume hood when working with dichloromethane or PCBs.
1. Formulation of polymeric implant
Working in a hood, add 7 g of P-80 and 0.7 g of F127 in 20 mL of dichloromethane in a 125 mL glass beaker.
Add the test compound (i.e., biphenyl-4-ol or a hydroxylated PCB metabolite) to the P-80/F127 mixture in dichloromethane.
Note: The amount of the test compound can be based on the percent of the total weight of the polymer (e.g., 1%, 5%, or 10% of the total weight, including the test compound, or 0.08, 0.41, or 0.86 g of the test compound, respectively). Alternatively, proceed directly to Step 3 to prepare the control implants with 0 % of the test compound.
Cover the solution to prevent the dichloromethane from evaporation
Allow about 45 minutes to dissolve the polymer, resulting in a clear solution (Figure 1).
Note: Add more dichloromethane if the solvent no longer covers the polymer pellets. The polymer dissolves faster if it forms an even layer in the beaker.
After 45 minutes, uncover and gently stir the polymer solution with a glass stir rod until the mixture is smooth and of a viscous consistency (this will be different depending on the amount of solvent added).
Place the beaker in an oil bath at 70 °C to evaporate the solvent by stirring occasionally. Stirring will help the solvent evaporate faster and more evenly.
Note: An oil bath is used to prevent water condensation from getting into the solution.
The polymer will return to its original whitish color (Picture 1) and should still be pliable; this will take about 20-30 min in the oil bath, depending on the amount of solvent added.
Picture 1: Appearance of the polymer mixture before extrusion.
2. Extrusion of the polymeric implants
Load the pliable polymer mixture with the desired amount of the test compound (or not test compound for the control implants) into a 5 mL disposable plastic syringe.
Attach silicone tubing with the desired internal diameter to the syringe. The diameter of the silicone tubing will determine the final diameter of the implants.
Place the syringe with the attached silicone tubing in an oven at 70°C for several minutes until the solution is clear.
Force the polymer mixture into the silicone tubing until approximately 7 to 8 cm of the tubing is evenly filled with the polymer mixture.
Note: The polymer mixture is very viscous, so there will be resistance when extruding into silicone tubing. Place the syringe back in the oven as necessary.
Replace the silicone tubing once the polymer mixture in the tubing reaches between 7 and 8 cm. Repeat this step until the syringe is empty.
Picture 2: Polymer after extrusion.
Let the extruded polymer mixture set for 24 h at room temperature.
Once the polymer has hardened, remove the mold by making a small incision along the silicone tubing.
Let molded polymer sit out overnight in a fume hood to remove any residual dichloromethane.
Cut implants to the desired length (e.g., 2 cm)
Place the implants in a vacuum oven for 2 h to remove residual dichloromethane (PiPiccture 3).
Picture 3: Final polymeric implants.
Weigh and measure each implant individually (Figure 3). The average diameter of implant is 2.3 ± 0.1 mm
Store implants in labeled amber glass vials at -80°C until use.
Protocol references
Aqil, F., J. Jeyabalan, H. Kausar, S. S. Bansal, R. J. Sharma, I. P. Singh, M. V. Vadhanam and R. C. Gupta (2012). "Multi-layer polymeric implants for sustained release of chemopreventives." Cancer Lett 326(1): 33-40.
Aqil, F., H. Shen, J. Jeyabalan, X. Xin, H. J. Lehmler, G. Ludewig, L. W. Robertson and R. C. Gupta (2014). "Sustained expression of CYPs and DNA adduct accumulation with continuous exposure to PCB 126 and PCB 153 through a new delivery method: Polymeric implants." Toxicol Rep 1: 820-833.
Gupta, R. C., S. S. Bansal, F. Aqil, J. Jeyabalan, P. Cao, H. Kausar, G. K. Russell, R. Munagala, S. Ravoori and M. V. Vadhanam (2012). "Controlled-release systemic delivery - a new concept in cancer chemoprevention." Carcinogenesis 33(8): 1608-1615.